Bioiberica Overview
- Year Founded
-
1975
- Status
-
Acquired/Merged
- Employees
-
304
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Bioiberica General Information
Description
Manufacturer of heparin API intended to improve people, animal and plant health and well-being. The company specializes in identifying, extracting and developing APIs and ingredients into Heparin products to progress the pharmaceutical, nutraceutical, veterinary, feed and agricultural industries, enabling its customers to avail the solution for improving their lives.
Contact Information
Website
www.bioiberica.com(Operating Subsidiary)
Corporate Office
- Av. Països Catalans 34, Planta 2
- Esplugues de Llobregat
- 08389 Barcelona
- Spain
Corporate Office
- Av. Països Catalans 34, Planta 2
- Esplugues de Llobregat
- 08389 Barcelona
- Spain
Bioiberica Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bioiberica Comparisons
Industry
Financing
Details
Bioiberica Competitors (12)
One of Bioiberica’s 12 competitors is DSM-Firmenich, a Corporation company based in Kaiseraugst, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DSM-Firmenich | Corporation | Kaiseraugst, Switzerland | ||||
| Abbott India | Corporation | Mumbai, India | ||||
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
| Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
Bioiberica Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bioiberica Patents
Bioiberica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240373859-A1 | Composition comprising bacillus siamensis strain for promoting plant growth | Pending | 09-May-2023 | ||
| EP-4461135-A1 | Composition comprising bacillus siamensis strain for promoting plant growth | Pending | 09-May-2023 | ||
| EP-4378319-A1 | Composition comprising bioactive peptides | Pending | 01-Dec-2022 | ||
| EP-4311552-A1 | Gastrointestinal protectant composition | Pending | 28-Jul-2022 | ||
| ES-2956802-A1 | Hydrogels for use in skin tissue engineering (machine-translation by google translate, not legally binding) | Pending | 20-May-2022 | A61L27/58 |
Bioiberica Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bioiberica Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bioiberica FAQs
-
When was Bioiberica founded?
Bioiberica was founded in 1975.
-
Where is Bioiberica headquartered?
Bioiberica is headquartered in Barcelona, Spain.
-
What is the size of Bioiberica?
Bioiberica has 304 total employees.
-
What industry is Bioiberica in?
Bioiberica’s primary industry is Pharmaceuticals.
-
Is Bioiberica a private or public company?
Bioiberica is a Private company.
-
What is the current valuation of Bioiberica?
The current valuation of Bioiberica is .
-
What is Bioiberica’s current revenue?
The current revenue for Bioiberica is .
-
Who are Bioiberica’s investors?
P&R has invested in Bioiberica.
-
Who are Bioiberica’s competitors?
DSM-Firmenich, Abbott India, GlaxoSmithKline Consumer Nigeria, Boehringer Ingelheim, and Pfizer Pakistan are some of the 12 competitors of Bioiberica.
-
When was Bioiberica acquired?
Bioiberica was acquired on 26-Sep-2011.
-
Who acquired Bioiberica?
Bioiberica was acquired by Teeuwissen Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
